Novartis AG Common Stock (NVS)
Net Receivables
$9.85B
Quarterly · Period ending: · USD
NVS Net Receivables
Latest reported$10.93Bperiod ending
Latest reported$10.93Bperiod ending
NVS FY Net Receivables ($4.23B → $10.93B)
Annual net receivables
High-resolution chart · PNG
NVS net receivables history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 10,934,019,000 | |
| 8,211,000,000 | |
| 9,376,000,000 | |
| 9,894,000,000 | |
| 9,621,000,000 | |
| 9,073,000,000 | |
| 9,171,960,358 | |
| 9,676,000,000 | |
| 10,070,000,000 | |
| 10,202,000,000 | |
| 10,551,000,000 | |
| 10,255,000,000 | |
| 12,623,000,000 | |
| 12,533,000,000 | |
| 12,373,000,000 | |
| 11,716,000,000 | |
| 10,010,000,000 | |
| 8,573,000,000 | |
| 8,504,000,000 | |
| 7,971,000,000 | |
| 6,563,000,000 | |
| 6,189,000,000 | |
| 5,480,000,000 | |
| 3,707,000,000 | |
| 3,228,000,000 | |
| 3,221,000,000 | |
| 4,429,000,000 | |
| 4,225,290,697 |